Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation; Stroke Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Not applicableStudy completedNCT02428140
What this trial is testing

Post-Embolic Rhythm Detection With Implantable Versus External Monitoring

Who this might be right for
StrokeAtrial FibrillationArrhythmias, Cardiac
University of Alberta 300
Not applicableStudy completedNCT03119116
What this trial is testing

Use of Direct Oral Anticoagulants in UK

Who this might be right for
Stroke
Bayer 31,336
Post-approval studies (Phase 4)Not Yet RecruitingNCT07237308
What this trial is testing

BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis

Who this might be right for
StrokeIschemicAtrial Fibrillation+2 more
Yonsei University 586
Testing effectiveness (Phase 2)Study completedNCT00684307
What this trial is testing

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
AstraZeneca 1,084
Not applicableStudy completedNCT02485873
What this trial is testing

Real-Life Evidence on Stroke Prevention in SPAF

Who this might be right for
Atrial Fibrillation (Prevention of Stroke)
Bayer 8,607
Not applicableLooking for participantsNCT03642509
What this trial is testing

Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
University of Aarhus 750
Not applicableUnknownNCT01522911
What this trial is testing

Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage

Who this might be right for
Atrial FibrillationStroke PreventionLeft Atrial Appendage
University of Leipzig 50
Not applicableUnknownNCT02743416
What this trial is testing

Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II

Who this might be right for
Atrial FibrillationStroke
Karolinska University Hospital 6,868
Not applicableStudy completedNCT02433366
What this trial is testing

Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,213
Not applicableStudy completedNCT03242278
What this trial is testing

Real-world Dosing Patterns of Rivaroxaban in the United States

Who this might be right for
Atrial Fibrillation
Bayer 12,507
Large-scale testing (Phase 3)Ended earlyNCT00580216
What this trial is testing

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Sanofi 3,773
Not applicableUnknownNCT04282993
What this trial is testing

Wearable Devices for Secondary Prevention of Ischemic Stroke

Who this might be right for
Stroke, IschemicAtrial Fibrillation
Campus Bio-Medico University 200
Testing effectiveness (Phase 2)Study completedNCT00623779
What this trial is testing

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Who this might be right for
Persistent or Permanent Non-valvular Atrial Fibrillation
AstraZeneca 128
Not applicableLooking for participantsNCT07224178
What this trial is testing

Left Atrial Strain and Cryptogenic Stroke

Who this might be right for
Ischemic Stroke, CryptogenicIschemic Stroke, EmbolicHemorrhagic Stroke+2 more
University of Pittsburgh 900
Not applicableStudy completedNCT02784717
What this trial is testing

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Who this might be right for
Stroke
Bayer 3,055
Post-approval studies (Phase 4)UnknownNCT02549963
What this trial is testing

Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban

Who this might be right for
Atrial FibrillationStroke
Shulin Wu 200
Testing effectiveness (Phase 2)Study completedNCT00448214
What this trial is testing

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 448
Not applicableStudy completedNCT01800006
What this trial is testing

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region

Who this might be right for
Atrial Fibrillation
Bayer 2,101
Not applicableStudy completedNCT04722679
What this trial is testing

Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.

Who this might be right for
Non-Valvular Atrial Fibrillation
Bayer 103
Next Page